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Abstract
Background: Information on the burden of malaria in early infancy is scarce. Young infants are relatively
protected against clinical malaria during the first six months of life due to the presence of maternal
antibodies and foetal haemoglobin, and have received relatively little attention with respect to research
and treatment guidelines. The World Health Organization provides treatment guidelines for children from
six months onwards, without specific treatment guidelines for the younger infants. A number of recent
reports however suggest that the burden in this young age group may be underestimated.
Methods: A retrospective review of paediatric hospital records at the Queen Elizabeth Central Hospital
in Blantyre from 1998 to 2008 from three data sources was carried out. The number of admitted infants
<6 months and ≤ 15 years was obtained from the registry books of the Paediatric-Nursery-Department
and the Malaria Research Laboratory. For the period 2001 - 2004, more detailed malaria related admission
information was available as part of an ongoing study on severe malaria, allowing a calculation of the
proportion of infants < 6 months of age among admissions in children < 5 years.
Results: Retrospective analysis of hospital records showed that over the course of these years, the
average annual proportion of paediatric admissions in children ≤ 15 years with confirmed malaria aged <6
months was 4.8% and ranged between 2.8%-6.7%. This proportion was stable throughout the seasons.
Between 2001-2004, 9.9% of admissions with confirmed malaria in children <5 years occurred in infants
<6 months, with numbers increasing steadily during the first six months of life.
Conclusions: These findings are consistent with recent reports suggesting that the burden of malaria
during the six first months of life may be substantial, and highlight that more research is needed on dose-
optimization, safety and efficacy of anti-malarials that are currently used off-label in this vulnerable patient
group.
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Infants below the age of six months are thought to be rel-
atively protected against clinical malaria due to the trans-
fer of maternal antibodies and the presence of foetal
haemoglobin, and consequently receive relatively little
attention with respect to research and policy guidelines on
treatment of uncomplicated malaria[1,2].
However, several recent reports of facility- and commu-
nity-based settings across sub-Saharan Africa include scat-
tered information indicating a higher burden of disease in
this age group than what is generally assumed and the
period of protection might be shorter than the widely
quoted six months [2,3]. Successful protection from
malaria with insecticide-treated nets and intermittent pre-
ventive therapy targeting infants specifically (IPTi) have
been associated with a marked reduction in malaria mor-
bidity in children <6 months. Similarly, the protective
effect that innate host-genetic factors, such as sickle cell
trait, has throughout childhood has been recognized dur-
ing the first six months of life [4,5].
Generally, reports that present data on young children do
not focus on young infants specifically. For example, Bas-
sat et al observed that nearly 8% of all paediatric malaria
admissions during the years 2003-2005 occurred in
infants below six months of age[6]. Eliades et al con-
ducted a community survey in under 5s in Togo in 2004
and showed that the prevalence of parasitaemia increased
rapidly from two months of age and the prevalence of par-
asitaemia with document fever remained stable from
three months onwards [7]. Neither groups specifically
highlight their findings in young infants.
With the current implementation of ACT across malaria
control programmes in sub-Saharan Africa [8,9], the lack
of attention to case-management in this group needs to be
addressed.
Currently, infants <6 months are generally excluded from
the regulatory trials of anti-malarials during the drug
development phase. The World Health Organization pro-
vides treatment guidelines for children with weights
above 5 kg and generally over five months, without spe-
cific treatment guidelines for the younger infants[10]. Cli-
nicians working in the tropics will stress that malaria is
not a rare event in the first six months of age and available
first and second line oral anti-malarials are widely used
off-label, based on the recommended mg/kg doses for
older children. Because of the rapid changes in body com-
position and maturation of organs, anti-malarials likely
have different pharmacokinetic profiles in the first few
months of life compared to older children, potentially
affecting the required therapeutic dose[11,12].
A better understanding of the burden of malaria in early
infancy would help drug developers and policy makers
target limited resources for research and drug develop-
ment to include this group. To add to the limited data
available, a study to determine the relative frequency of
hospital admissions due to malaria in infants <6 months
compared to older children was carried out retrospectively
reviewing hospital records from the main academic hospi-
tal in Blantyre, Malawi, over an eight-year period to eval-
uate the need for prospective burden assessment.
Methods
Study area
This retrospective review was conducted in the Queen
Elizabeth Central Hospital (QECH), Blantyre, Malawi, an
academic hospital serving a catchment population of
approximately one million. The hospital has 150 paediat-
rics beds, although occupation can exceed 300 at any
given time. Infants ≤ 6 months with malaria are admitted
to a dedicated ward for this age group: the Paediatric-
Nursery-Department. The children's Accident and Emer-
gency unit manages about 90,000 patients ≤ 15 years per
year, of whom about 30% are admitted to the wards. The
population catchment varies from urban in Blantyre, to
semi-urban in the greater Blantyre district. Malaria trans-
mission is seasonal with peak transmission occurring
from December to June. The incidence of clinical malaria
has been reported as 1.4, 0.59, and 0.11 episodes per-year
among children less than five years of age, 5-15 y year old
children, and adults.
Data sources and study population
A review of the hospital records from 1998 to 2008 was
carried out. Three main sources of information were avail-
able, in the years 1998, and 2005 to 2008, Information on
the number of infants < 6 months of age admitted to the
QECH was obtained from the registry books of the Paedi-
atric-Nursery-Department. The information included date
of admission, age in months (or in weeks or days in
neonates), sex, laboratory test results including malaria
smears (expressed quantitatively as negative, 1+, 2+ or 3+)
and packed cell volume (PCV)]. Registry books did not
record the clinical course or outcome of patients.
Information on the total number of children ≤ 15 years
old admitted to the hospital with malaria (defined as a
positive malaria smear on admission) was obtained from
record books kept by a dedicated "Malaria Research Labo-
ratory". This Laboratory conducts all the malaria tests for
admissions to the general and research paediatric wards in
children ≤ 15 years of age. The records books contain lim-
ited information, including patient identifiers, gender and
lab results (including malaria smears and PCV) but not
age.Page 2 of 6
(page number not for citation purposes)
Malaria Journal 2009, 8:310 http://www.malariajournal.com/content/8/1/310For the period 2001 - 2004, more detailed information
was available for individual admissions from the malaria
research laboratory database and clinical records. This
additional data was captured as part of an ongoing study
on Severe Malaria in African Children (SMAC) as
described in more detail previously[13]. The methodol-
ogy to capture the absolute numbers of children admitted
with malaria was essentially the same as in 1998 and
2005-2008 allowing the pooling of the datasets. The
SMAC database also provided more detailed information
on age, gender, and weight.
Data management and analysis
All the information was copied from the registry and lab-
oratory records into an Excel database. The descriptive sta-
tistical analyses were done with Excel 2007 (Microsoft
Corporation, USA) and SPSS version 15 (SPSS Inc, Chi-
cago, USA). In all analyses a malaria case was defined as
any child admitted to the hospital with a positive malaria
slide (asexual stages) regardless of the parasite density or
disease severity.
Results
A total of 26,413 children ≤ 15 years of age were admitted
with malaria in the eight-year period (1998, and 2001 to
2007). Of these, 1,572 were admitted in the Paediatric-
Nursery-Department, including 1,087 children <6
months and 439 infants aged ≤ 6 months (in 46 cases, age
was not recorded) (Figure 1).
The age distribution among these 1,087 infants <6
months is represented in Figure 2. The median (range) age
was 4.0 months (0.1-5.0) and 49.7% of infants were male.
The mean PCV value during the study period was 24.7%
(SD: 8.7).
The average annual number of admissions with positive
malaria parasitaemia in all age groups was 3,302 (SD:
2831), with a peak of admissions in 1998 (8947 patients),
with 25,326 children <15 yr and 1,087 infants < 6 months
(Figure 3). The average of the annual proportion of
malaria cases aged <6 months among the paediatric
admissions with positive malaria parasitaemia over the
course of these years, was 4.8% and ranged between 2.8%-
6.7% (Figure 4). While there was a strong seasonal trend
in malaria transmission and admission numbers, the pro-
portion of paediatric malaria admissions aged <6 month
was relatively stable throughout the year (Figure 4).
SMAC data: 2001-2004
A more detailed analysis by age group could be conducted
for the years 2001-2004. During this period, 83.7% of the
paediatric malaria admissions were aged <5 years old,
46.9% <2 years, 23.1% <12 months, 8.3% <6 months and
0.5% <2 months old. In other words, 9.9% of malaria
admissions in the under-5s were infants below 6 months.
The average weight of 305 infants <6 months of age
admitted with malaria was 6.2 kg (SD: 0.3) during the
2001-2004 when body weight data was collected, Among
this group, 47 infants (15.4%) had a weight <5 kg and
63.3% weighted between 5-7.5 Kg. The minimum weight
registered during the study period was 2.3 Kg (Figure 5).
Discussion
Between 1998 and 2007, on average 4.8% of children (≤
15 yrs) admitted to the Queen Elizabeth Central Hospital
Age distribution of malaria cases in children <15 years during the study periodFigure 1
Age distribution of malaria cases in children <15 years during the study period. Percentages and absolute numbers 
of malaria cases among infants <6 months by year and by season are also shown. Total number of malaria cases per year among 
infants <6 months old with percentage over the 8-year periodPage 3 of 6
(page number not for citation purposes)
Malaria Journal 2009, 8:310 http://www.malariajournal.com/content/8/1/310in Blantyre with confirmed malaria parasitaemia per year
were aged <6 months. This proportion was broadly simi-
lar across the seasons and years.
This finding supports a growing number of reports sug-
gesting that clinical malaria in infants <6 months old is
not a rare event. Although the risk is less than in older
infants, it appears to increase steadily from early infancy
onwards[14]. Eliades et al in Togo also observed a rapidly
increasing parasite prevalence and clinical malaria in a
random sample of children at community-level from the
age of two months onwards; with parasitaemia prevalence
increasing from 18.2% in children aged 0-2 months to
43.0% in children aged 3-5 months, and the prevalence of
parasitaemia with document fever remained stable from
three months onwards [7]. Afolabi et al reported similar
findings in a study conducted in Nigeria, where 27.1% of
all the admitted infants ≤ 6 months had positive malaria
parasitaemia, and malaria rates increased after the second
month of life[3]. Bloland et al estimated that 59.0% of
febrile episodes during the first five months of life in west-
ern Kenya were attributable to malaria[15]. Alonso and
colleagues in Mozambique reported that children <6
months accounted for more than 10% of all the registered
paediatric out-patient visits (almost 10,000 over a period
of 2 years and admitted infants <6 months with malaria
represent 4% of the malaria related admissions in chil-
dren <15 years[6,16].
While our findings contribute to the available data, this
retrospective review has several clear limitations. Because
of its retrospective nature and reliance on mostly routine
hospital records the quality and completeness of the avail-
able data varied over the years. The main finding of this
Age distribution of malaria cases in children <15 years during the study period*Figure 2
Age distribution of malaria cases in children <15 
years during the study period*. The percentage of chil-
dren <5 years was extrapolated from the data available dur-
ing 2001-2004
Age distribution of malaria cases in infants <6 months during the study peri dFigure 3
Age distribution of malaria cases in infants <6 
months during the study period.
Total number of malaria cases among infants <6 months dur-ing the study periodFi ure 4
Total number of malaria cases among infants <6 
months during the study period.
Percentage of infants with weight <5 Kg among all malaria cases in infants <6 months during 2001-2004 according toageFigure 5
Percentage of infants with weight <5 Kg among all 
malaria cases in infants <6 months during 2001-2004 
according to age.Page 4 of 6
(page number not for citation purposes)
Malaria Journal 2009, 8:310 http://www.malariajournal.com/content/8/1/310study is the annual proportion of young infants admitted
(4.8%), but this may underestimate the absolute number
of malaria cases in all age groups that were admitted. Not
all cases were recorded in the Registration Book at the
time of admission, and malaria smears may not have been
done for all children at the time of admission due to time
and staff constraints in a poor-resource setting. Neonates
with congenital malaria were not included either, as they
were admitted to the neonatal ward. A second limitation
is that multi-source data may generate some (biased) level
of error when all the data are pooled together. Further-
more, these in-patient data are not necessarily representa-
tive of the age distribution of clinical malaria in children
attending the out-patient clinics, or in the population. The
greater amount of malaria cases detected in 1998 can be
explained due to the effect that the meteorological phe-
nomenon of El Niňo had on the level of rainfall and the
subsequent increase in malaria transmission during this
particular year. Despite this considerable increase in
malaria transmission data form 1998 was poled with the
rest of the years included in the study because the propor-
tion of infants under six months admitted with malaria
during 1998 (3.9%) was similar to the one reported
among the rest of the study period. A similar season dis-
tribution in malaria cases among infants was observed in
1998 compared with the rest of the study period.
Despite these limitations, the results of this retrospective
review are consistent with a growing number of observa-
tions from both facility and community-level assessments
suggesting a higher burden in early infancy than generally
assumed. Children below five kg are not included in the
WHO treatment guidelines for the new ACT that are cur-
rently being implemented across the globe. Infants under
six months of age have also been systematically excluded
from the efficacy and safety trials that have been con-
ducted as part of the standard drug development process
for ACT[17]. Despite the lack of evidence-based guide-
lines, and mainly due to the absence of alternative recom-
mended treatment options, clinicians across Africa do use
these anti-malarials on a daily basis in this vulnerable age
group, using pragmatic experience to guide their decisions
on dosage. With the widely accepted notion that phar-
maco-kinetics and pharmaco-dynamics profile change
considerably in the first few months of life, it is crucial
that the current effort towards programmatic implemen-
tation of ACT needs to include this group.
Conclusion
The burden of malaria during the six first months of life is
probably underestimated, and may represent up to 5% of
all admitted paediatric malaria cases in children below 15
years. With the wide-scale implementation of artemisinin-
based combination therapy (ACT) for the case-manage-
ment of uncomplicated malaria throughout sub-Saharan
Africa, accurate estimates of burden, pharmacokinetic
profiles, safety and efficacy of ACT in early infancy are
urgently needed to guide the development of evidence-
based treatment guidelines for the different artemisinin-
based combinations that are currently used off-label in
this vulnerable patient group.
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